XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Interim Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 29, 2017
Sep. 29, 2017
Current assets:    
Cash and cash equivalents $ 596,390 $ 627,017
Restricted cash 7,630 7,351
Short-term investments 252,607 247,757
Accounts receivable, net of allowance for doubtful accounts of $4,087 and $2,967 122,917 73,750
Inventories 24,862 25,051
Prepaid expenses and other current assets 31,105 30,508
Total current assets 1,035,511 1,011,434
Long-term investments 303,501 314,364
Property, plant, and equipment, net 493,173 485,275
Intangible assets, net 195,205 189,648
Goodwill 311,186 311,087
Deferred taxes 139,658 190,915
Other non-current assets 36,475 30,831
Total assets 2,514,709 2,533,554
Current liabilities:    
Accounts payable 14,408 14,373
Accrued liabilities 178,419 207,034
Income taxes payable 6,906 1,216
Deferred revenue 23,449 23,150
Total current liabilities 223,182 245,773
Long-term deferred revenue 36,792 36,425
Other non-current liabilities 198,811 107,514
Total liabilities 458,785 389,712
Stockholders' equity:    
Additional paid-in capital 72,663 61,331
Retained earnings 1,985,064 2,083,063
Accumulated other comprehensive (loss) (8,122) (7,753)
Total stockholders’ equity – Dolby Laboratories, Inc. 2,049,707 2,136,742
Controlling interest 6,217 7,100
Total stockholders’ equity 2,055,924 2,143,842
Total liabilities and stockholders’ equity 2,514,709 2,533,554
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 60,541,095 shares issued and outstanding at December 29, 2017 and 59,281,837 at September 29, 2017    
Stockholders' equity:    
Common stock 59 58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 42,733,597 shares issued and outstanding at December 29, 2017 and 42,873,597 at September 29, 2017    
Stockholders' equity:    
Common stock $ 43 $ 43